About Index Trending news
Analyze
Top 50 Pricing
Celgene Corporation

Celgene Corporation

Work at Celgene Corporation? Add yourself to this profile

Celgene Corporation

Global biopharmaceutical company. Tweets by Greg Geissman & Julissa Viana. Review our guidelines on our site

Elsewhere

Alexa global traffic share

Twitter followers

Undisclosed amount VC (Undisclosed) in Oct, 2014
Exit: Adaptive Biotech for unknown amount on Jan 7, 2015
25.0M USD Private equity in Jun, 2014
Undisclosed amount Undisclosed funding in Nov, 2016
30.0M USD Series F in Dec, 2011
220.0M USD Series B in Apr, 2016
26.0M USD Series D in Dec, 2013
38.0M USD Series B in Dec, 2014
Exit: Bristol-Myers Squibb for $1.3B on Feb 23, 2015
61.5M USD Series A in Jan, 2016
12.0M USD Series B in Jun, 2010
44.0M USD Series C in Jan, 2007
78.0M USD Series C in Nov, 2011
100.0M USD Private equity in Jul, 2013
33.6M USD Series D in Jul, 2013
13.5M USD Series B in Jan, 2014
50.6M USD Series B in Sep, 2014
64.0M USD Series B in Apr, 2015
41.8M USD Series D in Apr, 2015
50.0M USD Series B in Apr, 2016
10.6M USD Series A in May, 2016
46.0M USD Series A in May, 2016
22.5M USD Series A in Jul, 2016
37.0M USD Series B in Aug, 2016
57.0M USD Series A in Jul, 2016
70.0M USD Series B in Sep, 2016

Want to see the complete list?
Go Pro!